{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:04:07Z","timestamp":1789693447989,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112837","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:55:31Z","timestamp":1787640931000},"page":"112837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cancer-associated fibroblast-derived vascular endothelial growth factor a promotes gastric cancer organoid growth and chemotherapy resistance via paracrine signaling"],"prefix":"10.1016","volume":"148","author":[{"given":"Hongmei","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linteng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cellsig.2026.112837_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202409050","article-title":"Super-enhancer activates master transcription factor NR3C1 expression and promotes 5-FU resistance in gastric cancer","volume":"12","author":"Yu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2026.112837_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114986","article-title":"Baicalin enhances the efficacy of 5-fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis","volume":"164","author":"Yuan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112837_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3393\/ac.2024.00388.0055","article-title":"Essential knowledge and technical tips for total mesorectal excision and related procedures for rectal cancer","volume":"40","author":"Cho","year":"2024","journal-title":"Ann. Coloproctol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112837_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12967-024-05301-9","article-title":"The tumour microenvironment, treatment resistance and recurrence in glioblastoma","volume":"22","author":"White","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112837_bb0025","article-title":"Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112837_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12935-018-0599-7","article-title":"Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer","volume":"18","author":"Ma","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112837_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10120-021-01270-w","article-title":"CAF promotes chemoresistance through NRP2 in gastric cancer","volume":"25","author":"Yang","year":"2022","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.cellsig.2026.112837_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101275","article-title":"Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer","volume":"82","author":"Xu","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112837_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2539442","article-title":"Inhibition of FAK promotes pancreatic cancer immunotherapy by mediating CXCL10 secretion to enhance CD8+ T cell infiltration","volume":"14","author":"Shi","year":"2025","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112837_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s44164-025-00084-9","article-title":"Colorectal carcinoma organoid and cancer-associated fibroblasts co-culture system for drug evaluation","volume":"4","author":"Wang","year":"2025","journal-title":"In vitro models"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112837_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","article-title":"Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112837_bb0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/CAD.0000000000001445","article-title":"Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer","volume":"34","author":"Shi","year":"2023","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.cellsig.2026.112837_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115304","article-title":"Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K\/AKT pathway","volume":"163","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"Pt 3","key":"10.1016\/j.cellsig.2026.112837_bb0070","article-title":"Silencing CXCR6 promotes epithelial-mesenchymal transition and invasion in colorectal cancer by activating the VEGFA\/PI3K\/AKT\/mTOR pathway","volume":"143","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112837_bb0075","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.99337.3","article-title":"Single-cell dissection of prognostic architecture and immunotherapy response in Helicobacter pylori infection-associated gastric cancer","volume":"13","author":"Zhang","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.cellsig.2026.112837_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117340","article-title":"Differences in chemotherapeutic drug sensitivity before and after patient-derived tumor organoid construction","volume":"499","author":"Shao","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112837_bb0085","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2026.112837_bb0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112837_bb0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112837_bb0100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/cells12040628","article-title":"Secretome of stromal cancer-associated fibroblasts (CAFs): relevance in cancer","volume":"12","author":"Mishra","year":"2023","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.cellsig.2026.112837_bb0105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/cells14171398","article-title":"Cancer-associated fibroblasts in solid tumors and sarcomas: heterogeneity, function, and therapeutic implications","volume":"14","author":"Badran","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.cellsig.2026.112837_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112837_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cell.2009.12.046","article-title":"Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development","volume":"140","author":"Lichtenberger","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112837_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031585","article-title":"Prostate cancer-associated fibroblasts: a review on CAF functions, heterogeneity, resistance mechanisms, and future in a chip","volume":"27","author":"Lupsa","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112837_bb0125","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1158\/0008-5472.CAN-25-2181","article-title":"Pan-cancer spatial profiling reveals conserved subtypes and niches of cancer-associated fibroblasts","volume":"85","author":"Jieun Kim","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112837_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1672020","article-title":"Spatial profiling of the metabolism-immune axis in ovarian cancer","volume":"16","author":"Wang","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112837_bb0135","article-title":"Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.cellsig.2026.112837_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-335683","article-title":"Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics","author":"Chen","year":"2026","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112837_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147087","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects","volume":"133","author":"Jain","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2026.112837_bb0150","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112837_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2026.112837_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156908","article-title":"The role of VEGF in cancer angiogenesis and tumorigenesis: insights for anti-VEGF therapy","volume":"189","author":"Shi","year":"2025","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112837_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102721","article-title":"VEGFA status as a predictive marker of therapy outcome in metastatic gastric cancer patients following ramucirumab-based treatment","volume":"11","author":"Schirizzi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cellsig.2026.112837_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156674","article-title":"Adaptive resistance of tumor cells to anti-vascular endothelial growth factor therapy: a reversible phenomenon","volume":"180","author":"Wang","year":"2024","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112837_bb0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"24","key":"10.1016\/j.cellsig.2026.112837_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413376","article-title":"The biological roles and clinical applications of the PI3K\/AKT pathway in targeted therapy resistance in HER2-positive breast cancer: a comprehensive review","volume":"25","author":"Zhong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112837_bb0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41571-023-00800-y","article-title":"New anti-angiogenic option for mCRC","volume":"20","author":"Killock","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112837_bb0190","first-page":"7903","article-title":"Metronomic chemotherapy remodel cancer-associated fibroblasts to decrease chemoresistance of gastric cancer in nude mice","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112837_bb0195","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600495X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600495X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:20:00Z","timestamp":1789690800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600495X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S089865682600495X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112837","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblast-derived vascular endothelial growth factor a promotes gastric cancer organoid growth and chemotherapy resistance via paracrine signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112837"}}